James F. McDonough
Of Counsel
732-568-8360 jmcdonough@sh-law.comFirm Insights
Walgreens urged to undergo tax "inversion"
Author: James F. McDonough
Date: April 30, 2014
Key Contacts
Back
Walgreens, a staple U.S. drugstore, has been headquartered in Illinois for almost a century. The company got its start in downstate Dixon, Ill., before moving its corporate headquarters to Chicago and then eventually to Deerfield, Ill., according to the Chicago Tribune. The company’s next corporate move may take it further away – to Bern, Switzerland.
A group of influential shareholders, including Goldman Sachs Investment Partners and hedge funds Jana Partners, Corvex and Och-Ziff, are reportedly pressuring the company to undergo a so-called “inversion,” according to the Financial Times. This move would allow Walgreens to relocate to Switzerland, paying a dramatically lower corporate income tax rate. The corporate income tax in the U.S. is among the highest in the world – a factor that has prompted a number of companies in the public eye to redomicile their headquarters abroad.
Analysts at UBS found that Walgreens’ tax rate was anticipated to be 37.5 percent this year, according to the news source. This is considerably higher than the tax rate for Alliance Boots, a formerly UK-based pharmacy chain of which Walgreens recently acquired 45 percent. Boots is anticipated to pay a tax rate of only 20 percent as a result of having made such an inversion a few years ago.
UBS explained in a note last month that Walgreens could increase earnings per share by 75 percent by undergoing an inversion, the news source explained. The finance group noted, however, that “Walgreens’ management seems more hesitant to pull the trigger near-term due to perceived political risks.”
Many think that Walgreens is right to be concerned about political risk, particularly because of recent attention paid to corporate tax in the U.S. and the face-to-face nature of the company’s interactions with the public. Inversions have become very popular in the last two years, FT explained, especially in the pharmaceutical sector.
- Practices: Tax and Trusts & Estates
- Locations: Red Bank, NJ, New York City, Little Falls, NJ
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Related Posts
See all
IP Infringement: What Steps Can You Take If You're Affected?
IP infringement occurs when someone uses your intellectual property without your permission or beyond the scope of the permission you granted. Common examples of IP infringement include copying a product’s patented features or using a trademarked logo in a way that is likely to confuse consumers about the source or affiliation of goods or services. […]
Author: Michael Mietlicki
Public Allegations, Unfinished Investigation: What New Jersey Businesses Should Do Next
When facing public allegations of wrongdoing, companies should not let the speed of the public conversation dictate the speed of an investigation. An investigation designed to confirm a preferred narrative rather than establish the facts can create serious problems later, particularly if litigation, regulatory scrutiny, or employment claims follow. Key Takeaways When public allegations surface […]
Author: Sean M. Pena
BESS Interconnection: Managing Grid, Cost, and Schedule Risk
For battery energy storage system (BESS) developers, securing equipment and site control is only part of the development equation. A project must also connect to the electric grid, and increasingly, BESS interconnection is one of the biggest sources of schedule, cost, and contractual risk. Key Takeaways This article is Part 3 of our Battery Storage […]
Author: Nicholas Wall
Navigating Director and Officer Liability in Times of Financial Distress
Director and officer liability increases sharply when a company is in financial distress. Decisions that would draw little attention in a healthy business can later be challenged by creditors, shareholders, bankruptcy trustees, and regulators as breaches of fiduciary duty, fraudulent transfers, or oversight failures. Understanding where that exposure comes from, and how to manage it, […]
Author: Michael Mietlicki
Before You Buy: Managing Real Estate and Permitting Risk for BESS Projects in New York and New Jersey
For developers pursuing battery energy storage system (BESS) projects, finding the right property is only the beginning. BESS site selection is as much a legal and transactional exercise as a real estate decision, with risk analysis central to the project’s ultimate success. Key Takeaways The core questions for BESS site selection in New York and […]
Author: Nicholas Wall
What Business Owners Get Wrong Before Meeting a Litigation Attorney
What should you expect when meeting a litigation attorney about a business dispute? You should expect to describe the dispute in your own words, hand over the most important documents, flag any deadlines or immediate threats, and leave with a clearer picture of the problem, what information is still needed, and the likely next steps. […]
Author: Michael Mietlicki
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.